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immunity which depended on the increase in the body mass index parameters and 
were more significant in the patients from NASH group.
THE PECULIARITIES OF THE INDEXES OF ACTIVATED RECEPTORS ON 
THE LYMPHOCYTES ACCORDING TO THE BODY MASS INDEX  
IN THE PATIENTS WITH NONALCOHOLIC FATTY LEAVER DEASE IN 
COMBINATION WITH THE OBESITY
Filippova A.Yu.  
SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine», Dnipro
In non-alcoholic fatty liver disease, the process of disease progression is of great 
importance. Recurrent, and in some cases continuous exacerbations are caused by 
both humoral and cellular immune disorders. Therefore, the study of the causes and 
progression mechanisms of fatty liver disease from the perspective of immunology is 
one of the relevant problems.
The objective of the research is to check the changes of the activated 
receptors on the lymphocytes according to the body mass index in the patients with 
comorbid course of nonalcoholic hepatic steatosis and nonalcoholic steatohepatitis in 
combination with the obesity and pathology of biliary tract.
Materials and methods. The study involved 200 patients with non-alcoholic 
fatty liver disease in conjunction with obesity and biliary tract pathology, who 
revealed signs of hepatic steatosis at the time of sonographic and morphological 
study of liver biopsy: 100 patients with nonalcoholic hepatic steatosis and obesity, 
100 – with nonalcoholic steatohepatitis and obesity (of which 70 with the minimal 
activity of the process in terms of alanine transaminase and 30 with the moderate 
activity). Depending on the degree of increase in the body mass index the patients 
with nonalcoholic hepatic steatosis and obesity and nonalcoholic steatohepatitis and 
obesity were divided into three subgroups: the first subgroup includes the patients 
with overweight, the second subgroup includes the patients with the first-degree 
obesity and the third subgroup includes the patients with the second-degree obesity. 
The control group consisted of 20 practically healthy persons. The subpopulation 
composition of the lymphocytes was determined using a monoclonal antibody by the 
«Sorbent TM» company to the clusters: CD25 + (receptors for IL-2), CD95 + (FAS / 
APO-1), HLA-DR+ by indirect immunofluorescence and CD16 + (natural killer cells) 
using lymphotoxic test.
Results and Discussion. It is determined that in all group of the observations 
the varied likely increase of the number of the activated receptors on lymphocytes is 
happening which according from the increase of the indices of the body mass index 
and it is more significant in the presence of the steatohepatitis in terms of CD16 +, 
CD25 +, CD95 + immune markers. In the group with nonalcoholic steatohepatitis with 
the moderate activity is a significant prerequisite for the implementation of lysis of the 
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target cells in terms of relative CD16 + lymphocytes (from p<0,001 and p<0,05). The 
level of CD25 + lymphocytes indicate a probable early cell activation in the all groups 
monitoring and activation of inflammation especially in patients with nonalcoholic 
steatohepatitis with moderate activity (from p<0,001 and p<0,05). It is determines 
that in the both nonalcoholic hepatic steatosis and nonalcoholic steatohepatitis the 
increased level of expression in CD95+ peripheral blood lymphocytes is observed, 
indicating a readiness to cell apoptosis and further progression of nonalcoholic fatty 
liver disease.
Conclusions. The patients with comorbid course of nonalcoholic hepatic steatosis 
and nonalcoholic steatohepatitis in combination with the obesity and pathology 
of biliary tract the authentic increase of the number of the activated receptors on 
lymphocytes is observed (CD16+, CD25+, CD95+) which according to the increase of 
the body mass index which is more significant in the presence of the steatohepatitis.
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Introduction. One of the most common diseases of the cardiovascular system in 
the world is arterial hypertension (AH). Today, the prevention of damage to «target 
organs» is important issue. It is well known that hypertension is associated with the 
development of asymptomatic brain lesions. But not always the control of the blood 
pressure improve symptoms such as headache, dizziness, confusion, fatigue, low 
mood, memory loss. 
Objectives. The aim of our study was to evaluate efficiency of the use of 
ethylmethyl-dyroxypiridine sukcinate in complex therapy in patients with arterial 
hypertension depending on renal function.
Methods. The study included 30 patients (mean age 65,2±6,2 years) with AH. 
Patients included in the study on the background of medicamentous correction of 
AH. To determine the degree of cognitive impairment was used the Montreal scale 
assessment of cognitive impairment (MoCA). To determine the level of disorders in 
psycho-emotional sphere we used the hospital anxiety scale (HADS-T) and hospital 
depression scale (HADS-D). The patients were divided into two groups depending on 
the level of glomerular filtration rate (GFR). The first group (11 persons) consisted 
of patients with AH with preserved renal function (GFR>90ml/min/1,73 m2), in this 
group to «basic» antihypertensive therapy we added ethylmethylhydroxypyridine 
succinate; the second group (10 persons) – patients with AH with reduced renal 
